Abstract
2-3 antigens mismatched BMT were performed on 32 children without a matched sibling donor. In the light of previous in vitro studies, which suggested a role of Vincristine and Methilprednisolone ex vivo treatment in modulating alloreactivity of T cells, bone marrow was treated with such a pharmacological cocktail before being infused. Acute GVHD 2° to 4° degree occurred in 46% of cases, chronic GVHD in 28%, graft failure in 13%. There was no significant difference between 2- and 3-antigens mismatched BMT as far as GVHD and graft failure are concerned.
| Original language | English |
|---|---|
| Pages (from-to) | 114-116 |
| Number of pages | 3 |
| Journal | Bone Marrow Transplantation |
| Volume | 11 |
| Issue number | SUPPL. 1 |
| Publication status | Published - 1993 |
ASJC Scopus subject areas
- Hematology
- Transplantation
Fingerprint Dive into the research topics of 'Low incidence of GvHD and rejection after pharmacological ex vivo modulation of bone marrow in 2-3 antigens mismatched BMT'. Together they form a unique fingerprint.
Cite this
De Manzini, A., Andolina, M., Agosti, E., Giorgi, R., Locatelli, F., Bonetti, L., Miniero, R., Busca, A., Porta, F., Lanfranchi, A., Rossetti, F., & Colleselli, P. (1993). Low incidence of GvHD and rejection after pharmacological ex vivo modulation of bone marrow in 2-3 antigens mismatched BMT. Bone Marrow Transplantation, 11(SUPPL. 1), 114-116.